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ABSTRACT 
Thyroid hormones play a crucial role in the functions of the nervous, reproductive, and 
cardiovascular systems in humans and have been shown to be sensitive to potential disruption of 
normal function by environmental contaminants. Several mechanisms have been studied in the 
role of environmental chemical exposure in alteration of thyroid hormones, including 
interference in iodine transport, thyroid hormone-binding proteins, deiodinases, and receptor 
binding. Uranium is a naturally occurring heavy metal that is found in the form of minerals in 
rocks, soil, surface water, groundwater, air, plants, and animals. The general population is 
primarily exposed to uranium through ingestion of uranium-contaminated food or water. We 
sought to examine the potential association between urinary uranium levels and serum thyroid 
hormones and antibodies in the U.S. population, using data from the National Health and 
Nutrition Examination Survey (2007-2010).   
We used multiple linear regression and multiple logistic regression models to investigate 
the potential association between environmental uranium exposure and thyroid function. 
Environmental uranium exposure was measured by urinary uranium concentration. Thyroid 
function was measured by serum concentrations of thyroid stimulating hormone (TSH), total and 
free thyroxine (TT4 and FT4, respectively), total and free triiodothyronine (TT3 and FT3), 
thyroglobulin (Tg), thyroglobulin antibody (TgAb), and thyroperoxidase antibody (TPOAb). We 
observed a negative linear relationship between urinary uranium and serum TT4 levels and a 
positive linear relationship between urinary uranium and serum thyroglobulin antibodies. 
Furthermore, subjects with elevated serum TSH had higher odds and those with elevated serum 
TT3 had lower odds of having been exposed to environmental uranium compared to those with 
lower serum TSH and TT3, respectively. More research is needed to identify specific 
mechanisms by which uranium affects thyroid function and to examine the association in 
populations with higher-than-normal exposures to uranium.   
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INTRODUCTION 
Thyroid hormones play a crucial role in the functions of the nervous, reproductive, and 
cardiovascular systems in humans [1,2,3]. They are produced and regulated by three main 
components: the thyroid gland, the hypothalamus, and the pituitary gland. When the 
hypothalamus detects that there are low levels of thyroid hormone circulating in the blood, it 
produces thyrotroponin-releasing hormone (TRH), which stimulates the pituitary gland to 
increase its production of thyroid stimulating hormone (TSH). The main role of TSH is to 
stimulate the thyroid gland to release thyroid hormones. This cycle operates in a negative 
feedback loop in which excess thyroid hormone circulating in the blood inhibits TRH and TSH 
production. Large glycoproteins called thyroglobulin are produced in the thyroid gland and 
iodinized to produce thyroid hormones. [4] 
The two main types of thyroid hormone are thyroxine (T4) and triiodothyronine (T3). 
Iodine is an important component of T4 and T4, and thus plays a critical role in the functioning of 
the thyroid gland. Approximately 90% of circulating thyroid hormones are in the form of T4 and 
about 10% in the form of T3. Both types are produced in the thyroid gland and released by Tg 
upon stimulation by TSH, although T4 is produced in much greater quantities compared to T3. 
Some of the circulating T4 converts to T3 at target cells. More than 95% of thyroid hormones 
circulating in the blood are bound to three main carrier proteins: thyroid-binding globulin (TBG), 
transthyretin, and albumin. The small amount of unbound, free T4 and T3 (often called FT4 and 
FT3) is believed to be metabolically active within the tissues. [4] 
Abnormal thyroid hormone levels in the blood can manifest as subclinical or overt 
hypothyroidism or hyperthyroidism. Subclinical hypothyroidism occurs when serum TSH levels 
are high but serum FT4 and FT3 concentrations are normal, and subclinical hyperthyroidism 
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occurs when serum TSH levels are low but FT4 and FT3 concentrations are normal [5]. Overt 
hypothyroidism is defined as low serum FT4 concentration with high serum TSH concentration. 
Overt hyperthyroidism can be defined as having very low serum TSH concentration with serum 
FT4 and total and FT3 levels above the normal reference range. [6] Table 1 shows the reference 
ranges for various thyroid hormones and antibodies. Currently, the serum TSH test is most 
widely used by clinicians to diagnose various types of thyroid dysfunction because of its high 
sensitivity [4]. 
One study reports that the prevalence of subclinical hypothyroidism in the US adult 
population is approximately 4-8.5% among those without known thyroid disease. Approximately 
2-5% of subclinical hypothyroidism cases progress to overt disease. The prevalence of 
subclinical hyperthyroidism is approximately 2%, and approximately 1-2% of those with serum 
TSH below 0.1 µIU/mL progress to overt hyperthyroidism. [6] 
Thyroglobulin (Tg), thyroglobulin antibodies (TgAb), and thyroperoxidase antibodies 
(TPOAb) also play important roles in the diagnosis of thyroid disease. Serum thyroglobulin 
measurement is an important clinical tool for patients with differentiated thyroid cancer (DTC) 
[4]. The presence of thyroglobulin antibodies in patients with DTC has been shown to interfere 
with serum Tg measurement [7]. TPO is an enzyme that is involved in the synthesis of thyroxine 
and triiodothyronine. The presence of TPO antibodies in the blood was found to predict a higher 
risk of developing overt hypothyroidism [6]. The presence of TgAb in the absence of TPOAb is 
not significantly associated with thyroid disease [8].  
Several mechanisms have been studied in the role of environmental chemical exposure in 
alteration of thyroid hormones, including interference in iodine transport, thyroid hormone-
binding proteins, deiodinases, and receptor binding [5]. The majority of studies investigating 
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thyroid hormones have focused on polychlorinated biphenyls (PCBs), polybrominated diphenyl 
ethers, and bisphenol A (BPA). [9,10]  
Uranium is a naturally occurring heavy metal that is found in the form of minerals in 
rocks, soil, surface water, groundwater, air, plants, and animals. The U.S. Environmental 
Protection Agency set the maximum contaminant level (MCL) for uranium in drinking water at 
30 µg/L. The MCL is enforced for public water systems, but not for private wells. [11] 
Health effects of uranium exposure vary depending on the chemical form of uranium, 
dose, and route of exposure. The general population is primarily exposed to uranium through 
ingestion of uranium-contaminated food or water. Persons living or working near abandoned 
uranium mines or hazardous waste sites can also be exposed to uranium by inhalation or dermal 
contact. Numerous studies have found that uranium mining is associated with increased deaths 
from lung cancer [12]. Several animal studies have shown that exposure to uranium through 
ingestion was associated with adverse effects on reproductive function and decreased fertility 
[13,14,15]. A study on rats found that uranium exposure through drinking water was associated 
with degeneration of thyroid epithelium and disturbance in thyroid function [16].  
Few human studies have examined the role of environmental heavy metals in thyroid 
function, and even fewer have specifically explored the uranium-thyroid association. One study 
that examined the relationship between heavy metals in blood and urine and thyroid function in 
NHANES 2007-2008 participants found that uranium concentrations in the urine was associated 
with decreased levels of total and free thyroxine in the blood [17]. However, this study 
investigated 15 other heavy metals as exposures and the authors reported that including multiple 
metals in their models may have led to unstable results due to collinearity among the exposures. 
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Furthermore, this study only investigated total and free T4, total and free T3, and TSH as primary 
outcomes.  
 This study aims to investigate the potential association between urinary uranium 
concentration and thyroid hormone and antibody levels in the U.S. adult population using data 
from the National Health and Nutrition Examination Survey (2007-2010). 
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METHODS: 
Data Source 
The National Health and Nutrition Examination Survey (NHANES) is a complex 
multistage stratified cluster survey that is designed to collect demographic, dietary, examination, 
laboratory, and questionnaire data from a nationally representative sample of the U.S. civilian 
population [18]. In 2007-2008, a sample of 10,149 subjects was included in the survey. In this 
cycle, measurements of thyroid function and of urinary uranium were taken for a subsample of 
6,200 participants 12 years and older and of 2,627 participants 6 years and older, respectively. In 
2009-2010, 10,537 participants were included in the survey. In this cycle, measurements of 
thyroid function and of urinary uranium were collected for a subsample of 2,262 subjects 12 
years and older and of 2,848 subjects 6 years and older, respectively.  
After combining data from the two cycles into an analytic dataset and excluding 
participants younger than 20 years of age, urinary uranium levels and serum thyroid hormone 
and antibody levels were measured in 3,537 adults. After further excluding subjects who 
reported a current thyroid problem (n=241), those who were pregnant based on a urine test 
(n=41), and had missing values for covariates (n=321) the analytic sample for this analysis 
consisted of 2,934 subjects. Figure 1 shows how the analytic sample was determined from the 
two NHANES cycles (2007-2008 and 2009-2010). 
 Taking sampling weights into consideration, this analytic sample represented 
165,593,286 non-pregnant adults in the U.S. general population who do not currently have a 
thyroid problem.  
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Urinary Uranium 
 In this analysis, urinary uranium (ug/L) was the primary exposure of interest. In 
NHANES 2007-2010, urine specimens were analyzed in the Division of Environmental Health 
Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and 
Prevention. The inductively coupled plasma-mass spectrometry (ICP-MS) method was used to 
measure uranium in the urine. Levels of uranium in urine reflect both recent and accumulated 
exposure [19,20]. 
Thyroid Hormone and Antibody Levels 
 Thyroid hormone and antibody levels were the primary outcomes of interest. Eight 
outcome variables were used in the analysis: thyroid stimulating hormone (TSH, uIU/mL), total 
thyroxine (TT4, ug/dL), free thyroxine (FT4, ng/dL), total triiodothyronine (TT3, ng/dL), free 
triiodothyronine (FT3, pg/mL), thyroglobulin (Tg, ng/mL), thyroglobulin antibodies (TgAb, 
IU/mL), and thyroid peroxidase antibodies (TPOAb, IU/mL). In 2007-2010, serum thyroid 
hormone and antibody levels were analyzed at the University of Washington in Seattle, WA. 
TSH level was measured using Access HYPERsensitive hTSH assay. TT4, TT3, and FT3 levels 
were determined using a competitive binding immunoenzymatic assay. FT4 level was measured 
using a two-step enzyme immunoassay. Tg level was measured using a simultaneous one-step 
assay. TgAb and TPOAb levels were measured using sequential two-step immunoenzymatic 
assays. [21,22] 
Statistical Analysis 
 We plotted the survey weight against urinary uranium to look for outliers, and none with 
extremely large survey weights were identified. Therefore, we did not exclude any exposure 
outliers in the analysis. Additionally, we plotted the survey weight against each of the outcome 
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variables to look for outliers, and none with extremely large survey weights were identified. 
Therefore, we did not exclude any outcome outliers in the analysis. The following variables were 
natural log-transformed for continuous models because the data were not normally distributed: 
uranium, TSH, TT4, FT4, TT3, and FT3. 
This analysis explored eight covariates and potential confounders: urinary creatinine, age, 
sex, race/ethnicity, poverty-to-income ratio (PIR), body mass index (BMI), serum cotinine, and 
urinary iodine. All were selected based on existing literature on the topic of environmental heavy 
metals and/or thyroid function [1,2,3,23]. Urinary creatinine was included in the models as a 
covariate because urinary uranium concentration is highly dependent on the level of urine 
dilution. Urine dilution may vary drastically from person to person and time to time depending 
on fluid consumption, physical activity level, and health [24]. PIR was included in the models to 
adjust for socioeconomic status. BMI was included because of its association with thyroid 
function. Serum cotinine was used as a proxy for smoking status, which is associated with 
thyroid disorders. Research has shown that active smokers almost always have serum cotinine 
concentrations that are higher than10 ng/mL while nonsmokers typically have serum cotinine 
concentrations that are less than 1 ng/mL [25]. Urinary iodine was used as a proxy for iodine 
status and was included in the models because iodine is essential in the body’s production of 
thyroid hormones. 
Urinary creatinine was treated as a continuous variable. Age and urinary iodine were 
treated as continuous variables while sex and race/ethnicity (non-Hispanic white, non-Hispanic 
black, Mexican Americans or other Hispanic, and other race including multi-racial) were treated 
as categorical variables in all of the models. We explored both continuous and categorical 
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treatment for the following variables: PIR (<1, 1-1.98, 1.99-3.78, ≥3.79), BMI (<25, 25-30, ≥30 
kg/m2), and serum cotinine (<3 and ≥3 ng/mL).  
We used both multiple linear regression and multiple logistic regression models in order 
to investigate the association between environmental uranium exposure and thyroid function. In 
the linear regression model, each of the outcome variables were treated as continuous variables. 
In the logistic regression model, TSH, Tg, TgAb, and TPOAb were categorized based on the 
reference ranges shown in Table 1. While clinical cut-points were also available for TT4, FT4, 
TT3, and FT3, these outcomes were categorized as below or above the median value for the 
analytic sample. This is because when TT4, FT4, TT3, and FT3 were categorized as low, normal, 
or high based on referenced ranges, the low cell counts in the low and high categories led to 
unstable odds ratio estimates. 
 With respect to the four independent variables with which we explored both continuous 
and categorical treatment, we chose to treat urinary uranium, PIR, BMI, and serum cotinine 
differently for the linear and logistic regression models. Our decision to treat each of these 
variables as either continuous or categorical was based on comparison of Akaike information 
criterion (AIC) values for the models, holding all other variables constant. For example, in 
deciding whether to treat urinary uranium as continuous or as quintiles in the multiple linear 
regression model for TSH, we compared the AIC values for these two models containing the 
following independent variables:  
Model 1: Uranium (continuous), creatinine, age, sex, race/ethnicity, PIR, BMI, cotinine, iodine 
vs. 
Model 2: Uranium (quintiles), creatinine, age, sex, race/ethnicity, PIR, BMI, cotinine, iodine. 
The model with the smaller AIC was chosen in order to select the best treatment of each variable.  
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 In the linear regression model, the AIC values did not appear meaningfully different for 
uranium, PIR, BMI, and cotinine for each of the outcomes. Therefore, we chose to treat each of 
these independent variables as continuous variables. In the logistic regression model, however, 
the AIC values appeared meaningfully different for the four variables, so we chose to treat 
uranium as categorical (quintile 1 as reference), PIR and BMI as continuous, and cotinine as 
categorical (<3 ng/mL as reference).  
For both linear and logistic regression, four combinations of covariates were investigated: 
urinary creatinine-only adjusted model, core model (adjusting for urinary creatinine, age, gender, 
and race/ethnicity), parsimonious model (adjusting for urinary creatinine, age, sex, and 
race/ethnicity, and various other covariates), and full model (adjusting for urinary creatinine, age, 
sex, race/ethnicity, PIR, BMI, serum cotinine, and urinary iodine). In the parsimonious models, 
covariates included varied for each outcome because covariates were selected using backward 
elimination. Covariates that were not statistically significant (p>0.1) were eliminated one at a 
time from the full model until all covariates remaining in the model were statistically significant. 
Independent variables selected for each outcome variable in both the linear and logistic models, 
as well as how each variable was treated are summarized in Table 2.  
In the logistic regression model where the uranium variable was categorized into 
quintiles, we tested for linear trend for the odds ratios. We also performed logistic regression 
with uranium as a continuous variable where the unit change was the interquartile range of 
uranium in the analytic sample (0.01 ug/L). 
All analyses were performed using SAS version 9.3. PROC SURVEYREG and PROC 
SURVEYLOGISTIC were used to generate regression parameters and odds ratios, respectively, 
in order to account for the sampling weights and complex survey methods of NHANES. 
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RESULTS 
 Descriptive characteristics for this study’s analytic sample are shown in Table 3 
(N=2,934). This analytic sample represented 165,593,286 adults in the U.S. general population 
with no reported thyroid disease or pregnancy. The mean age of the U.S. general population 
represented in this sample was 46. Approximately 53% of the subjects were male and 47% were 
female. Nearly half of the participants were non-Hispanic white, 20% non-Hispanic black, 28% 
Mexican American or other Hispanic, and 5% other race. Approximately 30% of the participants 
had a BMI <25 kg/m2 and 21% had income that was below the poverty threshold. Estimating that 
having serum cotinine concentration greater than or equal to 3 ng/mL indicates exposure to 
heavy cigarette smoke (including active smokers and those heavily exposed through second hand 
smoking), approximately 29% of the participants were heavily exposed to cigarette smoke. The 
mean urinary iodine concentration was 218.17 ug/L and the mean for urinary creatinine was 
119.56 mg/dL. 
 The weighted mean for serum thyroid hormone and antibody concentrations were: TSH, 
1.89 uIU/mL; TT4, 7.83ug/dL; FT4, 0.78 ng/dL; TT3, 114.96 ng/dL; FT3, 3.20 pg/mL; Tg, 15.35 
ng/mL; TgAb, 9.23 IU/mL; TPOAb, 18.26 IU/mL. The weighted mean for urinary uranium was 
0.013 ug/L. The mean creatinine-corrected urinary uranium concentration was 0.01 ug/g 
creatinine. 
 Statistically significant associations between ln-transformed urinary uranium and ln-
transformed serum TT4 and TPOAb were observed in the linear regression models (Table 4). A 
statistically significant negative association between uranium and TT4 as observed in the core 
(β=-0.016, p=0.031), parsimonious (β=-0.015, p=0.037; adjusted for age, sex, race/ethnicity, 
urinary creatinine, BMI, and urinary iodine), and full (β=-0.016, p=0.030) models. A statistically 
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significant positive association between uranium and TPOAb was observed in the parsimonious 
(β=3.702, p=0.040; adjusted for age, sex, race/ethnicity, urinary creatinine, and PIR) and full 
(β=3.237, p=0.045) models. There were no statistically significant associations between urinary 
uranium and TSH, FT4, TT3, FT3, Tg, and TgAb in any of the models. 
 Table 5 and Figure 2 show the odds ratios and 95% confidence intervals of urinary 
uranium in relation to categories of thyroid hormone and antibody levels. For serum TSH, which 
was categorized as low (<0.3 uIU/mL), normal (0.3-3.0 uIU/mL), or high (>3.0 uIU/mL), the 
odds ratio for participants with urinary uranium concentration in the third quintile was 
marginally statistically significant (OR=1.55, 95% CI: 1.05-2.31) compared to the first quintile 
(≤0.0030 ug/L), after adjusting for urinary creatinine only. The odds ratios remained statistically 
significant in the core (OR=1.56, 95% CI: 1.05-2.31), parsimonious (OR=1.57, 95% CI: 1.05-
2.36; adjusted for age, sex, race/ethnicity, urinary creatinine, and BMI), and full (OR=1.60, 95% 
CI: 1.06-2.42) models. For serum TT3 concentration, categorized as below the median (<112 
ng/dL) or above the median (≥112 ng/dL), the odds ratios were marginally statistically 
significant for only the fifth quintile of urinary uranium for the creatinine-only adjusted 
(OR=0.64, 95% CI: 0.45-0.91), core (OR=0.68, 95% CI: 0.45-0.98), parsimonious (OR=0.66, 
95% CI: 0.45-0.98), and full (OR=0.66, 95% CI: 0.44-0.98) models compared to the first 
quintile. For TgAb, participants were categorized as negative or positive for TgAb in their blood 
(≤4.0 IU/mL or >4.0 IU/mL, respectively). The odds ratios for TgAb were statistically 
significant for the second quintile of urinary uranium compared to the first quintile in the 
creatinine-only adjusted model (OR=2.01, 95% CI: 1.21-3.34). Odds ratio for TgAb remained 
significant in the core (OR=1.86, 95% CI: 1.12-3.09), parsimonious (OR=1.86, 95% CI: 1.12-
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3.09; adjusted for age, sex, race/ethnicity, and urinary creatinine), and full (OR=1.92, 95% CI: 
1.15-3.19) models. 
 The tests for trend for urinary uranium quintiles in the logistic regression models for all 
of the outcomes were statistically non-significant (Table 5). The odds ratios for interquartile 
range change in urinary uranium were also statistically non-significant for all outcomes (Table 
5). 
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DISCUSSION 
In this study, we investigated the association between urinary uranium levels and thyroid 
hormones and antibodies in the U.S. general population using data from the National Health and 
Nutrition Examination Survey (2007-2010).  
The mean creatinine-corrected urinary uranium concentration was 0.01 ug/g creatinine, 
which was similar to the mean concentrations found in other studies. One study collected spot 
urine specimen from a sample of Gulf War veterans who were not exposed to depleted uranium 
(N=23) and found that their mean urinary uranium level was 0.02 ug/g creatinine. [1]. Another 
study that investigated the relationship between metals in urine and blood and thyroid function 
using data from NHANES 2007-2008 found that the median urinary uranium concentration was 
0.006 ug/L, before correcting for urinary creatinine [17]. In this study, the median uncorrected 
urinary uranium concentration was also 0.006 ug/L. 
Previous research has suggested that exposure to environmental heavy metals may affect 
thyroid function in humans [1,2,3,23]. Animal models have suggested that exposure to uranium 
may have adverse effects on reproductive and thyroid function [13,14,15,16]. Our study 
observed a negative linear relationship between urinary uranium and serum TT4 levels, although 
the association was not seen in the logistic regression models. For serum TSH, those with high 
serum TSH levels versus the combined normal and low TSH levels had 60% greater odds of 
having been exposed to moderate levels of environmental uranium (third quintile). In addition, 
those who had serum TT3 levels above the median had 34% lower odds of having been exposed 
to high levels of uranium (quintile 5).  Finally, our study observed a positive linear relationship 
between uranium exposure and serum Tg antibodies. This association was also seen in the 
logistic regression model where those who tested positive for Tg antibodies had 92% greater 
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odds compared to those who tested negative for Tg antibodies of having been exposed to 
moderately low levels of uranium (quintile 2). Results of the parsimonious models were similar 
to that of full models, indicating that adjusting for age, sex, race/ethnicity, urinary creatinine, 
PIR, BMI, urinary iodine, and serum cotinine in the relationship between urinary uranium and 
serum thyroid hormones and antibodies was appropriate.  
Abnormal thyroid hormone and antibody levels in the blood have important clinical 
implications, although interpretation of these levels can be complicated. There has been much 
controversy over the suitability of diagnostic testing and treatment for subclinical thyroid disease 
because its clinical significance is uncertain [5]. However, subclinical hyperthyroidism and 
hypothyroidism can progress to overt thyroid disease that can significantly affect the quality of 
life for patients. Those who have overt hyperthyroidism have an overactive thyroid, which can 
cause sudden weight loss, fatigue, goiter, increased sweating, and rapid or irregular heartbeat 
[27]. Patients who have hypothyroidism often suffer from slow metabolism, weight gain, fatigue, 
joint and muscle pain, and decreased sweating [28].    
This study has several limitations. Because of the cross-sectional nature of NHANES, we 
were not able to assess a causal relationship between environmental uranium exposure and 
abnormal thyroid function. Furthermore, urinary uranium concentration was based on a single 
urine sample, which may only represent recent exposure. Therefore, effect of chronic exposure to 
environmental uranium is difficult to derive from this analysis. We were unable to categorize 
total and free thyroxine and total and free triiodothyronine serum concentrations as low, normal, 
and high because there were too few observations in the low and high categories. Instead, we 
used the median value for each of these outcomes to categorize them as below or above the 
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median. Because we did not use clinical reference ranges for these outcomes, the results may be 
challenging to interpret. 
Urinary dilution correction by using specific gravity or osmolality has been proposed as 
alternatives to using urinary creatinine adjustment [29]. However, we used urinary creatinine 
adjustment because other measures of urinary dilution were not available in the NHANES 
dataset. Next, because the covariates included in our models were initially selected based on 
existing literature on the effect of environmental chemical exposure on thyroid function, we did 
not use a specific statistical threshold for inclusion of the covariates in our models. Instead, in the 
parsimonious model for each outcome, backward elimination method was used to eliminate 
statistically nonsignificant (p>0.1) covariates.  
Despite the limitations, this study has several strengths. A strength associated with using 
data from NHANES is that it contains data for many important potential confounders that we 
were able to adjust for in our models. Furthermore, because NHANES uses a multistage 
probability sampling design, the results of this study are generalizable to the entire civilian, non-
institutionalized U.S. adult population.  
In addition, this study has advantages over a previous study that investigated the 
relationship between metals in blood and urine and thyroid function [17]. Combining data from 
two NHANES cycles—2007-2008 and 2009-2010—in this study allowed for a large sample size 
(N=2,934). The study by Christensen et al used one NHANES cycle (2007-2008) and therefore 
had a sample size that was approximately half of that which was used in this study. Finally, our 
study only included urinary uranium concentration as the primary exposure variable rather than 
including other serum or urinary heavy metal variables in order to avoid confounding or 
collinearity among the exposures.  
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In conclusion, we observed a negative linear relationship between urinary uranium and 
serum TT4 levels and a positive linear relationship between urinary uranium and serum 
thyroglobulin antibodies. Furthermore, subjects with elevated serum TSH had higher odds and 
those with elevated serum TT3 had lower odds of having been exposed to environmental uranium 
compared to those with lower serum TSH and TT3, respectively. More research is needed to 
identify specific mechanisms by which environmental uranium affects thyroid function. 
Moreover, future studies should explore the uranium-thyroid association in populations with 
higher levels of exposures such as occupationally exposed individuals or among residents of 
western United States since health effects of uranium may occur at exposure levels higher than 
experienced by the U.S. general population. 
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Table 1. Referenced ranges for thyroid hormonesa and antibodiesb 
Thyroid Hormones Low Normal High 
   TSH (µIU/mL) <0.4 0.4-6.0 >6.0 
   Total T4 (ng/dL) <4.5 4.5-12.6 >12.6 
   Free T4 (ng/dL) <0.7 0.7-1.8 >1.8 
   Total T3 (ng/dL) <80 80-220 >220 
   Free T3 (pg/mL) <2.0 2.0-5.0 >5.0 
   Tg (ng/mL) <5 5-25 >25 
Anti-thyroid antibodies Negative Positive 
 
   TgAb (IU/mL) <4.0 ≥4.0 
 
   TPOAb (IU/mL) <9.0 ≥9.0 
 
a
 Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., ... & Woeber, K. A. 
(2012). Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American 
Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine 
Practice,18(6), 988-1028. 
 b Gallagher, C. M., & Meliker, J. R. (2012). Mercury and thyroid autoantibodies in US women, NHANES 
2007–2008. Environment international, 40, 39-43. 
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Table 2. Summary of selection and treatment of independent variables in multiple linear 
regression and multiple logistic regression models 
Outcome variables Creatinine-only 
adjusted model Core model
a Parsimonious 
modelb Full model 
Linear regression  
  TSH 
Uranium (cont.) 
Creatinine (cont.) 
 
+Age (cont.) 
+Sex (cat.) 
+Race/ethnicity (cat.) 
 
+PIR (cont.) 
+BMI (cont.) 
Uranium (cont.) 
Creatinine (cont.) 
Age (cont.) 
Sex (cat.) 
Race/ethnicity (cat.) 
PIR (cont.) 
BMI (cont.) 
Cotinine (cont.) 
Iodine (cont.) 
  TT4 
+BMI (cont.) 
+Iodine (cont.) 
  FT4 +Iodine (cont.) 
  TT3 
+PIR (cont.) 
+BMI (cont.) 
+Cotinine (cont.) 
+Iodine (cont.) 
  FT3 
+PIR (cont.) 
+BMI (cont.) 
+Cotinine (cont.) 
+Iodine (cont.) 
  Tg 
+BMI (cont.) 
+Cotinine (cont.) 
+Iodine (cont.) 
  TgAb +Iodine (cont.) 
  TPOAb +PIR (cont.) 
Logistic regression  
  TSH 
Uranium (cat.) 
Creatinine (cont.) 
+Age (cont.) 
+Sex (cat.) 
+Race/ethnicity (cat.) 
 
+BMI (cont.) 
Uranium (cat.) 
Creatinine (cont.) 
Age (cont.) 
Sex (cat.) 
Race/ethnicity (cat.) 
PIR (cont.) 
BMI (cont.) 
Cotinine (cat.) 
Iodine (cont.) 
 
  TT4 
+PIR (cont.) 
+BMI (cont.) 
  FT4 +None 
  TT3 
+PIR (cont.) 
+BMI (cont.) 
+Iodine (cont.) 
  FT3 
+BMI (cont.) 
+Cotinine (cat.) 
+Iodine (cont.) 
  Tg 
+BMI (cont.) 
+Cotinine (cat.) 
+Iodine (cont.) 
  TgAb +None 
  TPOAb +BMI (cont.) 
a
 In addition to independent variables listed in the creatinine-only adjusted model 
b
 In addition to independent variables listed in the creatinine-only adjusted and core models 
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Table 3. Descriptive characteristics of NHANES 2007-2010 participants aged 20 and older with 
no missing values for THs, uranium, and covariates who are not currently pregnant and do not 
currently have a thyroid problem (N=2,934) 
 
Adults (ages 20+) 
Characteristic N Column % Weighted Mean 
Weighted 
95% CI NHANES Range 
Age 
 
 46.02 44.94-47.10 20-80 
  20-39 1014 38.75    
  40-59 963 39.03    
  ≥60 957 22.22    
Sex 
 
 
  
 
  Male 1543 52.59 
  
 
  Female 1391 47.41 
  
 
Race/ethnicity 
 
 
  
 
  White (non-Hispanic) 1405 47.89 
  
 
  Black (non-Hispanic) 566 19.29 
  
 
  Mexican American or Hispanic 815 27.78 
  
 
  Other 148 5.04 
  
 
BMI (kg/m2) 
 
 28.44 28.12-28.76 13.18-67.71 
  <25 858 29.24 
  
 
  25-30 1017 34.66 
  
 
  ≥30 1059 36.09 
  
 
Poverty-to-income ratio (PIR) 
 
 2.99 2.86-3.13 0.00-5.00 
  <1 630 21.47 
  
 
  1-1.98 779 26.55 
  
 
  1.99-3.78 757 25.80 
  
 
  ≥3.79 768 26.18 
  
 
Serum cotinine (ng/mL) 
 
 63.21 54.83-71.58 0.01-1160.00 
  <3 2097 71.47 
  
 
  ≥3  837 28.53 
  
 
Urinary iodine (ug/L)   218.17 206.36-264.00 7.70-34017.00 
Urinary creatinine (mg/dL)   119.56 115.67-123.46 8.00-528.00 
Serum thyroid hormone levels 
 
 
  
 
  TSH (uIU/mL) 
 
 1.89 1.82-1.95 0.01-69.84 
    Low (<0.3) 35 1.19 
  
 
    Normal (0.3-3.0) 2541 86.61 
  
 
    High (>3.0) 358 12.20 
  
 
  TT4 (ug/dL)   7.83 7.72-7.93 2.40-16.80 
     Below median (<7.8) 1455 49.59    
     Above median (≥7.8) 1479 50.41    
  FT4 (ng/dL)   0.78 0.77-0.79 0.20-3.40 
     Below median (<0.8) 1372 46.76    
     Above median (≥0.8) 1562 53.24    
  TT3 (ng/dL)   114.96 113.11-116-80 38.00-401.00 
     Below median (<112) 1410 48.06    
     Above median (≥112) 1524 51.94    
  FT3 (pg/mL) 
 
 3.20 3.18-3.23 1.80-28.84 
     Below median (<3.12) 1466 49.97    
     Above median (≥3.12) 1468 50.03    
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  Tg (ng/mL)   15.35 14.25-16.46 0.07-1210.90 
    Low (<5) 554 18.88    
    Normal (5-25) 1976 67.35    
    High (>25) 404 13.77 
  
 
  TgAb (IU/mL) 
 
 9.23 5.03-13.43 0.60-1614.50 
    Negative (≤4) 2763 93.89 
  
 
    Positive >4) 171 6.11 
  
 
  TPOAb (IU/mL) 
 
 18.26 14.84-21.67 0.10-2376.00 
    Negative (≤9.0) 2654 89.78 
  
 
    Positive (>9.0) 280 10.22 
  
 
Urinary uranium (ug/L) 
 
 0.013 0.009-0.016 0.00-1.82 
  Quintile 1 (≤0.0030) 614 20.93    
  Quintile 2 (0.0030-0.0052) 567 19.33    
  Quintile 3 (0.0053-0.0086) 594 20.25    
  Quintile 4 (0.0087-0.0151) 576 19.63 
  
 
  Quintile 5 (>0.0152) 583 19.87 
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Table 4. Regression coefficients, standard errors, and p-values of ln-transformed urinary uranium levels in relation to ln-transformed THs for 
creatinine-only adjusted, core, parsimonious, and full models 
 
a Adjusted for urinary creatinine only 
b Adjusted for age, gender, race/ethnicity, and urinary creatinine 
c Adjusted for covariates selected through backward elimination (eliminated if p>0.1), different covariates selected for each outcome 
d Adjusted for age, gender, race/ethnicity, urinary creatinine, PIR, BMI, serum cotinine, and urinary iodine 
e Ln-transformed 
 
  
Thyroid 
hormones/ 
antibodiese 
Unadjusteda  Core modelb  Parsimonious modelc  Full modeld 
β Estimate SE P-Value  β Estimate SE P-Value  β Estimate SE P-Value  β Estimate SE P-Value 
TSH 0.016 0.017 0.355  0.011 0.018 0.564  0.017 0.018 0.371  0.020 0.020 0.318 
TT4 -0.012 0.007 0.109  -0.016 0.007 0.031  -0.015 0.007 0.037  -0.016 0.007 0.030 
FT4 0.001 0.006 0.824  0.001 0.006 0.922  0.001 0.006 0.923  0.000 0.006 0.978 
TT3 -0.013 0.006 0.052  -0.011 0.007 0.129  -0.012 0.007 0.080  -0.012 0.007 0.080 
FT3 -0.002 0.004 0.603  0.002 0.004 0.689  0.001 0.004 0.847  0.001 0.004 0.847 
Tg 0.010 0.034 0.779  0.019 0.035 0.596  -0.002 0.033 0.958  -0.002 0.033 0.954 
TgAb 3.229 2.997 0.290  2.949 2.901 0.317  2.949 2.901 0.317  2.881 3.040 0.350 
TPOAb 3.637 1.812 0.053  3.226 1.792 0.081  3.702 1.729 0.040  3.237 1.548 0.045 
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Table 5. Odds ratios and 95% confidence intervals of urinary uranium quintiles in relation to THs for creatinine-only adjusted, core, parsimonious 
and full models 
Thyroid 
hormones/ 
antibodiese 
Uraniumf 
Unadjusted modela Core modelb Parsimonious modelc Full modeld 
OR Lower 95% CI 
Upper 
95% CI OR 
Lower 
95% CI 
Upper 
95% CI OR 
Lower 
95% CI 
Upper 
95% CI OR 
Lower 
95% CI 
Upper 
95% CI 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
TSH   Quintile 2 1.31 0.88 1.94 1.27 0.86 1.87 1.24 0.84 1.84 1.27 0.85 1.90 
 
  Quintile 3 1.55 1.05 2.31 1.56 1.05 2.31 1.57 1.05 2.36 1.60 1.06 2.42 
 
  Quintile 4 1.19 0.79 1.78 1.16 0.77 1.76 1.18 0.77 1.79 1.22 0.79 1.88 
 
  Quintile 5 1.48 0.92 2.37 1.39 0.86 2.25 1.43 0.87 2.34 1.48 0.90 2.45 
   p-trend 0.20   0.30   0.24   0.19   
 Continuous             
   IQR (0.01) 1.00 0.99 1.02 1.00 0.99 1.01 1.00 0.99 1.02 1.00 0.99 1.02 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
TT4   Quintile 2 0.89 0.67 1.18 0.83 0.61 1.12 0.81 0.60 1.09 0.81 0.60 1.09 
   Quintile 3 1.04 0.77 1.40 0.94 0.70 1.28 0.94 0.69 1.29 0.95 0.70 1.28 
   Quintile 4 0.88 0.62 1.24 0.79 0.55 1.12 0.79 0.55 1.12 0.79 0.55 1.14 
   Quintile 5 0.92 0.61 1.39 0.83 0.54 1.26 0.83 0.55 1.26 0.84 0.55 1.29 
   p-trend 0.72   0.41   0.45   0.49   
 Continuous             
   IQR (0.01) 0.99 0.97 1.01 0.99 0.97 1.01 0.99 0.97 1.01 0.99 0.97 1.01 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
FT4   Quintile 2 0.90 0.69 1.18 0.89 0.67 1.19 0.89 0.67 1.19 0.89 0.67 1.18 
   Quintile 3 1.00 0.70 1.42 0.98 0.68 1.42 0.98 0.68 1.42 0.98 0.68 1.41 
   Quintile 4 1.02 0.76 1.36 0.98 0.73 1.31 0.98 0.73 1.31 0.97 0.73 1.29 
   Quintile 5 0.99 0.72 1.36 0.95 0.69 1.32 0.95 0.69 1.32 0.95 0.69 1.31 
   p-trend 0.79   0.99   0.99   0.98   
 Continuous             
   IQR (0.01) 1.02 1.00 1.04 1.02 1.00 1.04 1.02 1.00 1.04 1.02 1.00 1.04 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
TT3   Quintile 2 0.77 0.57 1.05 0.81 0.62 1.07 0.80 0.59 1.08 0.80 0.59 1.08 
   Quintile 3 0.79 0.61 1.03 0.82 0.63 1.06 0.82 0.62 1.07 0.81 0.62 1.07 
   Quintile 4 0.84 0.60 1.18 0.87 0.62 1.21 0.87 0.62 1.22 0.86 0.61 1.22 
   Quintile 5 0.64 0.45 0.91 0.67 0.45 0.98 0.66 0.45 0.98 0.66 0.44 0.98 
   p-trend 0.06   0.11   0.12   0.12   
 Continuous             
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   IQR (0.01) 0.96 0.92 1.01 0.96 0.91 1.02 0.96 0.91 1.02 0.96 0.91 1.02 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
FT3   Quintile 2 0.96 0.71 1.29 1.10 0.82 1.46 1.07 0.80 1.43 1.07 0.80 1.43 
   Quintile 3 0.88 0.67 1.16 0.99 0.73 1.34 0.99 0.73 1.34 0.98 0.72 1.34 
   Quintile 4 1.08 0.83 1.42 1.23 0.96 1.56 1.21 0.93 1.57 1.21 0.93 1.56 
   Quintile 5 1.11 0.81 1.51 1.36 0.93 2.00 1.36 0.93 1.99 1.34 0.91 1.98 
   p-trend 0.36   0.09   0.10   0.11   
 Continuous             
   IQR (0.01) 1.02 1.00 1.03 1.02 1.00 1.04 1.02 1.00 1.04 1.02 1.00 1.04 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
Tg   Quintile 2 1.23 0.89 1.69 1.23 0.91 1.67 1.15 0.86 1.54 1.15 0.86 1.54 
 
  Quintile 3 1.29 0.94 1.78 1.32 0.94 1.84 1.25 0.91 1.72 1.25 0.91 1.72 
 
  Quintile 4 1.08 0.76 1.55 1.14 0.79 1.65 1.03 0.71 1.48 1.03 0.71 1.48 
 
  Quintile 5 1.31 0.90 1.93 1.39 0.95 2.05 1.25 0.86 1.81 1.25 0.86 1.81 
   p-trend 0.37     0.23     0.48     0.49     
 Continuous             
   IQR (0.01) 1.00 0.99 1.01 1.00 0.99 1.01 1.00 0.99 1.01 1.00 0.99 1.01 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
TgAb   Quintile 2 2.01 1.21 3.34 1.86 1.12 3.09 1.86 1.12 3.09 1.92 1.15 3.19 
 
  Quintile 3 1.21 0.68 2.14 1.12 0.64 1.95 1.12 0.64 1.95 1.15 0.66 2.02 
 
  Quintile 4 1.80 1.02 3.17 1.63 0.92 2.87 1.63 0.92 2.87 1.70 0.94 3.07 
 
  Quintile 5 1.59 0.87 2.94 1.38 0.72 2.64 1.38 0.72 2.64 1.45 0.78 2.68 
   p-trend 0.26     0.54     0.54     0.42     
 Continuous             
   IQR (0.01) 1.01 0.99 1.02 1.00 0.99 1.02 1.00 0.98 1.02 1.00 0.98 1.02 
 Quintile             
   Quintile 1 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 
TPOAb   Quintile 2 1.17 0.71 1.93 1.08 0.65 1.79 1.08 0.65 1.80 1.10 0.65 1.84 
 
  Quintile 3 1.11 0.61 2.02 1.00 0.55 1.82 0.99 0.54 1.80 1.00 0.55 1.85 
 
  Quintile 4 1.42 0.80 2.51 1.28 0.71 2.32 1.27 0.70 2.30 1.29 0.70 2.37 
 
  Quintile 5 1.56 0.95 2.55 1.35 0.79 2.31 1.32 0.78 2.24 1.37 0.80 2.36 
   p-trend 0.14     0.31     0.35     0.30     
 Continuous             
   IQR (0.01) 1.01 0.99 1.04 1.01 0.99 1.03 1.00 0.98 1.02 1.00 0.99 1.01 
              
a Adjusted for urinary creatinine only. 
b Adjusted for age, gender, race/ethnicity, and urinary creatinine. 
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c Adjusted for covariates selected through backward elimination (eliminated if p>0.1), different covariates selected for each outcome. 
d Adjusted for age, gender, race/ethnicity, urinary creatinine, PIR, BMI, serum cotinine, and urinary iodine. 
e Treated as ordinal or binary: TSH (low vs. normal vs. high); TT4 (below vs. above median); FT4 (below vs. above median), TT3 (below vs. above median); FT3 
(below vs. above median); Tg (low vs. normal vs. high); TgAb (negative vs. positive); TPOAb (negative vs. positive). 
f  Urinary uranium levels were treated as categorical (quintiles, where referent group was quintile 1) and as continuous (where the unit of change was the 
interquartile range of uranium, 0.01 ug/L). 
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Figure 2. Estimated odds ratios and 95% confidence intervals for thyroid hormones and 
antibodies according to urinary uranium quintiles, adjusted for age, sex, race/ethnicity, urinary 
creatinine, PIR, BMI, serum cotinine, and urinary iodine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
